Search Count: 19
 |
Structure Of Anti-Hcd33 Conditional Scfv With Methotrexate
Organism: Camelidae mixed library
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2020-11-18 Classification: ANTITUMOR PROTEIN Ligands: PO4, GOL, MTX |
Organism: Camelidae mixed library
Method: X-RAY DIFFRACTION
Release Date: 2020-11-18
Ligands: PO4, GOL, MTX
 |
Structure Of Anti-Hcd33 Conditional Scfv
Organism: Camelidae mixed library
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2020-11-04 Classification: ANTITUMOR PROTEIN Ligands: GOL, PEG, K, TRS |
Organism: Camelidae mixed library
Method: X-RAY DIFFRACTION
Release Date: 2020-11-04
Ligands: GOL, PEG, K, TRS
 |
Crystal Structure Of The Egfr Kinase Domain (L858R, T790M, V948R) In Complex With A Covalent Inhibitor N-[(3R,4R)-4-Fluoro-1-{6-[(1-Methyl-1H-Pyrazol-4-Yl)Amino]-9-(Propan-2-Yl)-9H-Purin-2-Yl}Pyrrolidin-3-Yl]Propanamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.46 Å Release Date: 2017-03-22 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 8BP, SO4, GOL |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2017-03-22
Ligands: 8BP, SO4, GOL
 |
Crystal Structure Of The Egfr Kinase Domain (L858R, T790M, V948R) In Complex With A Covalent Inhibitor N-[(3R,4R)-4-Fluoro-1-{6-[(3-Methoxy-1-Methyl-1H-Pyrazol-4-Yl)Amino]-9-(Propan-2-Yl)-9H-Purin-2-Yl}Pyrrolidin-3-Yl]Propanamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.33 Å Release Date: 2017-03-22 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 8AM, SO4, GOL, EDO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2017-03-22
Ligands: 8AM, SO4, GOL, EDO
 |
Crystal Structure Of The Egfr Kinase Domain (L858R, T790M, V948R) In Complex With 4-(4-{[2-{[(3S)-1-Acetylpyrrolidin-3-Yl]Amino}-9-(Propan-2-Yl)-9H-Purin-6-Yl]Amino}Phenyl)-1-Methylpiperazin-1-Ium
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.82 Å Release Date: 2017-03-22 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 8BM, SO4, GOL |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2017-03-22
Ligands: 8BM, SO4, GOL
 |
Crystal Structure Of The Egfr Kinase Domain In Complex With 4-(4-{[2-{[(3S)-1-Acetylpyrrolidin-3-Yl]Amino}-9-(Propan-2-Yl)-9H-Purin-6-Yl]Amino}Phenyl)-1-Methylpiperazin-1-Ium
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.53 Å Release Date: 2017-03-22 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 8BM |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2017-03-22
Ligands: 8BM
 |
Crystal Structure Of The Egfr Kinase Domain (L858R, T790M, V948R) In Complex With A Covalent Inhibitor N-[(3R,4R)-4-Fluoro-1-{6-[(3-Methoxy-1-Methyl-1H-Pyrazol-4-Yl)Amino]-9-Methyl-9H-Purin-2-Yl}Pyrrolidin-3-Yl]Propanamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.58 Å Release Date: 2017-03-22 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 8BS, SO4, GOL, EDO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2017-03-22
Ligands: 8BS, SO4, GOL, EDO
 |
Egfr (L858R, T790M, V948R) In Complex With N-{3-[(2-{[4-(4-Methylpiperazin-1-Yl)Phenyl]Amino}-7H-Pyrrolo[2,3-D]Pyrimidin-4-Yl)Oxy]Phenyl}Prop-2-Enamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.52 Å Release Date: 2016-02-03 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 633, SO4, GOL |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2016-02-03
Ligands: 633, SO4, GOL
 |
Egfr (L858R, T790M, V948R) In Complex With N-[3-({2-[(1-Methyl-1H-Pyrazol-4-Yl)Amino]-7H-Pyrrolo[2,3-D]Pyrimidin-4-Yl}Oxy)Phenyl]Prop-2-Enamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.42 Å Release Date: 2016-02-03 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 634, SO4, GOL |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2016-02-03
Ligands: 634, SO4, GOL
 |
Egfr (L858R, T790M, V948R) In Complex With 1-[(3R,4R)-3-[({2-[(1-Methyl-1H-Pyrazol-4-Yl)Amino]-7H-Pyrrolo[2,3-D]Pyrimidin-4-Yl}Oxy)Methyl]-4-(Trifluoromethyl)Pyrrolidin-1-Yl]Prop-2-En-1-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.15 Å Release Date: 2016-02-03 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 63A, SO4, GOL |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2016-02-03
Ligands: 63A, SO4, GOL
 |
Egfr (L858R, T790M, V948R) In Complex With 1-{(3R,4R)-3-[5-Chloro-2-(1-Methyl-1H-Pyrazol-4-Ylamino)-7H-Pyrrolo[2,3-D]Pyrimidin-4-Yloxymethyl]-4-Methoxy-Pyrrolidin-1-Yl}Propenone (Pf-06459988)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2016-01-27 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 630, SO4 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2016-01-27
Ligands: 630, SO4
 |
Catalytic Unit Of Pi3Kg In Complex With Pi3K/Mtor Dual Inhibitor Pf-04979064
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.35 Å Release Date: 2013-11-20 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 19P |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2013-11-20
Ligands: 19P
 |
Crystal Structure Of Glucokinase-Activator Complex
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.70 Å Release Date: 2013-07-24 Classification: Transferase/transferase activator Ligands: GLC, 926 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2013-07-24
Ligands: GLC, 926
 |
4-Methylpteridineones As Orally Active And Selective Pi3K/Mtor Dual Inhibitors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.75 Å Release Date: 2010-09-22 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: OAW |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2010-09-22
Ligands: OAW
 |
Discovery Of The Highly Potent Pi3K/Mtor Dual Inhibitor Pf-04691502 Through Structure Based Drug Design
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.70 Å Release Date: 2010-06-02 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: ML8 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2010-06-02
Ligands: ML8
 |
Discovery Of The Highly Potent Pi3K/Mtor Dual Inhibitor Pf-04691502 Through Structure Based Drug Design
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.55 Å Release Date: 2010-06-02 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: ML9 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2010-06-02
Ligands: ML9
 |
Characterization Of The Chk1 Allosteric Inhibitor Binding Site
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.76 Å Release Date: 2009-10-06 Classification: TRANSFERASE Ligands: AGX |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2009-10-06
Ligands: AGX
 |
Characterization Of The Chk1 Allosteric Inhibitor Binding Site
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2009-10-06 Classification: TRANSFERASE Ligands: AGY |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2009-10-06
Ligands: AGY
 |
N-(Pyridin-2-Yl) Arylsulfonamide Inhibitors Of 11B-Hydroxysteroid Dehydrogenase Type 1: Discovery Of Pf-915275
Organism: Cavia porcellus
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2009-08-04 Classification: Oxidoreductase/Oxidoreductase inhibitor Ligands: NAP, 3G4 |
Organism: Cavia porcellus
Method: X-RAY DIFFRACTION
Release Date: 2009-08-04
Ligands: NAP, 3G4